| LABCORP HLDGS INC. O.N. |
| USA |
| Gesundheit |
| US5049221055 / A40C39 |
| N6B (Frankfurt) / LH (NYSE) |
| FRA:N6B, ETR:N6B, N6B:GR, NYSE:LH |
| - |
| https://www.labcorp.com/ |
|
Labcorp Holdings Inc. is a leading provider of laboratory services, operating through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. It delivers a comprehensive array of diagnostic tests, including blood chemistry a..
>Volltext.. |
| 19469.36 Mio. EUR |
| 24584.57 Mio. EUR |
| 12086.56 Mio. EUR |
| 1903.55 Mio. EUR |
| 759.32 Mio. EUR |
| 9.13 EUR |
| 5653.57 Mio. EUR |
| 461.14 Mio. EUR |
| 1421.19 Mio. EUR |
| 0.19 |
| -5.47% |
| 3.56% |
| 2.47 EUR |
| 1.09% |
| 1.08% |
| 27.02.26 - 0.609264€ 26.11.25 - 0.621864€ >weitere anzeigen... |
| LABCORP |
| 04.04.26 |
|
||||
|
||||
|